These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 10797299

  • 1. Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.
    Van Der Looij M, Szabo C, Besznyak I, Liszka G, Csokay B, Pulay T, Toth J, Devilee P, King MC, Olah E.
    Int J Cancer; 2000 Jun 01; 86(5):737-40. PubMed ID: 10797299
    [Abstract] [Full Text] [Related]

  • 2. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.
    Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, Sagi M, Zlotogora J, Heching N, Peretz T.
    Am J Hum Genet; 1997 Mar 01; 60(3):505-14. PubMed ID: 9042909
    [Abstract] [Full Text] [Related]

  • 3. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.
    Levy-Lahad E, Catane R, Eisenberg S, Kaufman B, Hornreich G, Lishinsky E, Shohat M, Weber BL, Beller U, Lahad A, Halle D.
    Am J Hum Genet; 1997 May 01; 60(5):1059-67. PubMed ID: 9150153
    [Abstract] [Full Text] [Related]

  • 4. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.
    Moslehi R, Chu W, Karlan B, Fishman D, Risch H, Fields A, Smotkin D, Ben-David Y, Rosenblatt J, Russo D, Schwartz P, Tung N, Warner E, Rosen B, Friedman J, Brunet JS, Narod SA.
    Am J Hum Genet; 2000 Apr 01; 66(4):1259-72. PubMed ID: 10739756
    [Abstract] [Full Text] [Related]

  • 5. Germline mutation analysis of BRCA1 and BRCA2 genes in Yugoslav breast/ovarian cancer families.
    Papp J, Raicevic L, Milasin J, Dimitrijevic B, Radulovic S, Olah E.
    Oncol Rep; 1999 Apr 01; 6(6):1435-8. PubMed ID: 10523726
    [Abstract] [Full Text] [Related]

  • 6. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland.
    van Der Looij M, Wysocka B, Brozek I, Jassem J, Limon J, Olah E.
    Hum Mutat; 2000 May 01; 15(5):480-1. PubMed ID: 10790213
    [Abstract] [Full Text] [Related]

  • 7. Founder BRCA1 and BRCA2 mutations in early-onset French Canadian breast cancer cases unselected for family history.
    Tonin PN, Perret C, Lambert JA, Paradis AJ, Kantemiroff T, Benoît MH, Martin G, Foulkes WD, Ghadirian P.
    Int J Cancer; 2001 May 20; 95(3):189-93. PubMed ID: 11307153
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients.
    Yazici H, Bitisik O, Akisik E, Cabioglu N, Saip P, Muslumanoglu M, Glendon G, Bengisu E, Ozbilen S, Dincer M, Turkmen S, Andrulis IL, Dalay N, Ozcelik H.
    Br J Cancer; 2000 Sep 20; 83(6):737-42. PubMed ID: 10952777
    [Abstract] [Full Text] [Related]

  • 10. A family with three germline mutations in BRCA1 and BRCA2.
    Liede A, Metcalfe K, Offit K, Brown K, Miller S, Narod SA, Moslehi R.
    Clin Genet; 1998 Sep 20; 54(3):215-8. PubMed ID: 9788724
    [Abstract] [Full Text] [Related]

  • 11. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
    Cierniková S, Tomka M, Kovác M, Stevurková V, Zajac V.
    Neoplasma; 2006 Sep 20; 53(2):97-102. PubMed ID: 16575464
    [Abstract] [Full Text] [Related]

  • 12. BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic.
    Shih HA, Couch FJ, Nathanson KL, Blackwood MA, Rebbeck TR, Armstrong KA, Calzone K, Stopfer J, Seal S, Stratton MR, Weber BL.
    J Clin Oncol; 2002 Feb 15; 20(4):994-9. PubMed ID: 11844822
    [Abstract] [Full Text] [Related]

  • 13. A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer.
    Lu KH, Cramer DW, Muto MG, Li EY, Niloff J, Mok SC.
    Obstet Gynecol; 1999 Jan 15; 93(1):34-7. PubMed ID: 9916952
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer.
    Hodgson SV, Heap E, Cameron J, Ellis D, Mathew CG, Eeles RA, Solomon E, Lewis CM.
    J Med Genet; 1999 May 15; 36(5):369-73. PubMed ID: 10353781
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients.
    Rashid MU, Zaidi A, Torres D, Sultan F, Benner A, Naqvi B, Shakoori AR, Seidel-Renkert A, Farooq H, Narod S, Amin A, Hamann U.
    Int J Cancer; 2006 Dec 15; 119(12):2832-9. PubMed ID: 16998791
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Patients with double primary tumors in the breast and ovary- clinical characteristics and BRCA1-2 mutations status.
    Fishman A, Dekel E, Chetrit A, Lerner-Geva L, Bar-Am A, Beck D, Beller U, Ben-Baruch G, Piura B, Friedman E, Struewing JP, Modan B.
    Gynecol Oncol; 2000 Oct 15; 79(1):74-8. PubMed ID: 11006035
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer.
    Robson M, Dabney MK, Rosenthal G, Ludwig S, Seltzer MH, Gilewski T, Haas B, Osborne M, Norton L, Gilbert F, Offit K.
    Genet Test; 1997 Oct 15; 1(1):47-51. PubMed ID: 10464625
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.